Navigation Links
USC Center For Applied Molecular Medicine To Honor Sumner Redstone And Murray Gell-Mann, Ph.D. At The Inaugural REBELS WITH A CAUSE Gala
Date:9/18/2012

LOS ANGELES, Sept. 18, 2012 /PRNewswire/ -- USC Center for Applied Molecular Medicine honors Sumner M. Redstone and Nobel Laureate Murray Gell-Mann, Ph.D. at its REBELS WITH A CAUSE gala, September 19, 2012, at the Four Seasons Los Angeles at Beverly Hills.  The evening will raise funds to support the lifesaving research of David B. Agus, M.D., Director, USC Westside Cancer Center and USC Center for Applied Molecular Medicine.  Carmen A. Puliafito, M.D., M.B.A., Dean, Keck School of Medicine of USC is Honorary Co-Chair; Beverly and Robert Cohen Co-Chair.  The gala will feature performances by Tony Bennett and Neil Young; Tracey Ullman, emcees.

Sumner M. Redstone, Executive Chairman of Viacom and CBS Corporation has been Chairman of the Board of National Amusements since 1986, and CEO since 1967. He is a member of the Advisory Council for the ATAS Foundation and is on the Board of Trustees for The Paley Center for Media. He also served as COB of the National Association of Theatre Owners, and is currently a member of its Executive Committee. Before that, he was President of the Theatre Owners of America. Mr. Redstone was recently honored with a star on the Hollywood Walk of Fame. Mr. Redstone has devoted himself to a wide variety of civic and community affairs efforts, contributing over $150 million to worthy charities.

Murray Gell-Mann, Ph.D., is a Distinguished Fellow at the Santa Fe Institute as well as the Robert Andrews Millikan Professor Emeritus at the California Institute of Technology. In 2010, he was appointed Presidential Professor of physics and medicine at USC. In 1969 he received the Nobel Prize in physics for his work on the theory of elementary particles.  He is the author of The Quark and the Jaguar.

The goal of the USC Center for Applied Molecular Medicine is the development of novel treatment strategies for cancer.  The Center was implemented to enable multiple disciplines to work on treatment and the care of patients with cancer.  The program includes the clinical care of patients at the USC Westside Cancer Center and has team members with expertise spanning cancer biology, biochemistry, molecular biology, bioinformatics, computer science, electrical engineering, bioorganic chemistry, physics and applied mathematics.  http://camm.usc.edu/.


'/>"/>
SOURCE USC Center for Applied Molecular Medicine
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
2. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
3. New UCLA Engineering research center to revolutionize nanoscale electromagnetic devices
4. Center will create self-powered health monitoring devices
5. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
6. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
7. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
8. New Physician Joins Dallas Based Fertility Center
9. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
10. Breathe Better With Clarity Allergy Center
11. InVigor® Canola Supports Langdon Day Care Center with More for Everyone Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
Breaking Biology News(10 mins):